• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断帕金森病中轻度认知障碍的稳定性

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.

作者信息

Lawson Rachael A, Yarnall Alison J, Duncan Gordon W, Breen David P, Khoo Tien K, Williams-Gray Caroline H, Barker Roger A, Burn David J

机构信息

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

出版信息

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648-652. doi: 10.1136/jnnp-2016-315099. Epub 2017 Mar 1.

DOI:10.1136/jnnp-2016-315099
PMID:28250029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5537517/
Abstract

BACKGROUND

Mild cognitive impairment (MCI) is common in early Parkinson's disease (PD). We evaluated the stability of PD-MCI over time to determine its clinical utility as a marker of disease.

METHODS

212 newly diagnosed participants with PD were recruited into a longitudinal study and reassessed after 18 and 36 months. Participants completed a range of clinical and neuropsychological assessments. PD-MCI was classified using Movement Disorders Society Task Force level I (Montreal Cognitive Assessment <26) and level II (using cut-offs of 1, 1.5 and 2SD) criteria.

RESULTS

After 36 months, 75% of participants returned; 8% of patients had developed a dementia all of which were previously PD-MCI. Applying level I criteria, 70% were cognitively stable, 19% cognitively declined and 11% improved over 36 months. Applying level II criteria (1, 1.5 and 2SD), 25% were cognitively stable, 41% cognitively declined, 15% improved and 19% fluctuated over 36 months. 18% of participants reverted to normal cognition from PD-MCI.

DISCUSSION

Cognitive impairment in PD is complex, with some individuals' function fluctuating over time and some reverting to normal cognition. PD-MCI level I criteria may have greater clinical convenience, but more comprehensive level II criteria with 2SD cut-offs may offer greater diagnostic certainty.

摘要

背景

轻度认知障碍(MCI)在早期帕金森病(PD)中很常见。我们评估了PD-MCI随时间的稳定性,以确定其作为疾病标志物的临床效用。

方法

212名新诊断的PD参与者被纳入一项纵向研究,并在18个月和36个月后重新评估。参与者完成了一系列临床和神经心理学评估。使用运动障碍协会工作组一级(蒙特利尔认知评估<26)和二级(使用1、1.5和2个标准差的临界值)标准对PD-MCI进行分类。

结果

36个月后,75%的参与者返回;8%的患者发展为痴呆,所有这些患者之前均为PD-MCI。应用一级标准,70%的患者认知稳定,19%的患者认知下降,11%的患者在36个月内有所改善。应用二级标准(1、1.5和2个标准差),25%的患者认知稳定,41%的患者认知下降,15%的患者有所改善,19%的患者在36个月内波动。18%的参与者从PD-MCI恢复到正常认知。

讨论

PD中的认知障碍很复杂,一些个体的功能随时间波动,一些个体恢复到正常认知。PD-MCI一级标准可能具有更大的临床便利性,但采用2个标准差临界值的更全面的二级标准可能提供更大的诊断确定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/5537517/ba6bf9d60202/jnnp-2016-315099f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/5537517/ba6bf9d60202/jnnp-2016-315099f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/5537517/ba6bf9d60202/jnnp-2016-315099f01.jpg

相似文献

1
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.新诊断帕金森病中轻度认知障碍的稳定性
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648-652. doi: 10.1136/jnnp-2016-315099. Epub 2017 Mar 1.
2
Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.评估运动障碍协会工作组一级帕金森病轻度认知障碍诊断标准的效用。
Parkinsonism Relat Disord. 2015 Jan;21(1):31-5. doi: 10.1016/j.parkreldis.2014.10.020. Epub 2014 Oct 28.
3
Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.认知特征及常规认知测试在老年帕金森病、帕金森病痴呆、阿尔茨海默病及认知正常个体中的最佳截断值。
Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25.
4
Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.帕金森病中的轻度认知障碍:诊断及向痴呆的进展
J Clin Exp Neuropsychol. 2016;38(1):40-50. doi: 10.1080/13803395.2015.1087465. Epub 2015 Nov 25.
5
Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.使用帕金森病轻度认知障碍运动障碍学会工作组标准定义认知障碍的最佳截断分数。
Mov Disord. 2013 Dec;28(14):1972-9. doi: 10.1002/mds.25655. Epub 2013 Oct 9.
6
An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.帕金森病轻度认知障碍运动障碍学会工作组诊断标准评估。
Eur J Neurol. 2018 Jan;25(1):148-153. doi: 10.1111/ene.13467. Epub 2017 Oct 16.
7
Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.帕金森病中的轻度认知障碍及其向痴呆症的进展:登比郡队列的16年结局评估。
Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11.
8
Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease.帕金森病的整体评估、认知特征和轻度认知障碍的特点。
Int J Geriatr Psychiatry. 2023 Jun;38(6):e5955. doi: 10.1002/gps.5955.
9
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.哪些神经心理学测试可以预测帕金森病患者的认知下降和痴呆?ICICLE-PD 队列研究。
J Parkinsons Dis. 2021;11(3):1297-1308. doi: 10.3233/JPD-212581.
10
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis.帕金森病向 MCI 和痴呆的转化:系统评价和荟萃分析。
Parkinsonism Relat Disord. 2019 Aug;65:20-31. doi: 10.1016/j.parkreldis.2019.04.020. Epub 2019 May 7.

引用本文的文献

1
Inflammatory changes in early dementia with Lewy bodies.路易体痴呆早期的炎症变化。
Front Neurol. 2025 Aug 26;16:1640614. doi: 10.3389/fneur.2025.1640614. eCollection 2025.
2
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.路易体痴呆显性和前驱期生物学框架的意义与机遇
Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.
3
Machine Learning for Early Detection of Cognitive Decline in Parkinson's Disease Using Multimodal Biomarker and Clinical Data.

本文引用的文献

1
Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.新发帕金森病的认知功能减退与生活质量:注意力的作用
Parkinsonism Relat Disord. 2016 Jun;27:47-53. doi: 10.1016/j.parkreldis.2016.04.009. Epub 2016 Apr 11.
2
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.新诊断帕金森病中的轻度认知障碍:一项纵向前瞻性研究。
Parkinsonism Relat Disord. 2015 Oct;21(10):1219-26. doi: 10.1016/j.parkreldis.2015.08.024. Epub 2015 Aug 21.
3
Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
利用多模态生物标志物和临床数据的机器学习用于帕金森病认知衰退的早期检测
Biomedicines. 2024 Dec 3;12(12):2758. doi: 10.3390/biomedicines12122758.
4
The identification of cognitive impairment in Parkinson's disease using biofluids, neuroimaging, and artificial intelligence.利用生物流体、神经影像学和人工智能识别帕金森病中的认知障碍。
Front Neurosci. 2024 Sep 26;18:1446878. doi: 10.3389/fnins.2024.1446878. eCollection 2024.
5
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).帕金森病中的心血管自主神经功能障碍与认知障碍(综述)
Med Int (Lond). 2024 Sep 19;4(6):70. doi: 10.3892/mi.2024.194. eCollection 2024 Nov-Dec.
6
Cognition and Activity of Daily Living Function in people with Parkinson's disease.帕金森病患者的认知和日常生活活动功能。
J Neural Transm (Vienna). 2024 Oct;131(10):1159-1186. doi: 10.1007/s00702-024-02796-w. Epub 2024 Jul 8.
7
GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson's Disease.GWAS 鉴定 DPP6 为帕金森病认知下降的风险基因。
J Gerontol A Biol Sci Med Sci. 2024 Aug 1;79(8). doi: 10.1093/gerona/glae155.
8
Predicting the occurrence of mild cognitive impairment in Parkinson's disease using structural MRI data.利用结构磁共振成像数据预测帕金森病患者轻度认知障碍的发生情况。
Front Neurosci. 2024 Apr 18;18:1375395. doi: 10.3389/fnins.2024.1375395. eCollection 2024.
9
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease.帕金森病中小脑认知功能相关神经递质系统综述。
Neural Regen Res. 2024 Feb;19(2):324-330. doi: 10.4103/1673-5374.379042.
10
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.快速眼动睡眠行为障碍中伴路易体的前驱期痴呆:一项多中心研究。
Alzheimers Dement. 2024 Jan;20(1):91-102. doi: 10.1002/alz.13386. Epub 2023 Jul 17.
根据运动障碍学会(MDS)工作组标准诊断帕金森病轻度认知障碍(PD-MCI):需要多少项以及哪些神经心理学测试?
Mov Disord. 2015 Mar;30(3):402-6. doi: 10.1002/mds.26084. Epub 2014 Dec 1.
4
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.患有帕金森病且简易精神状态检查表(MMSE)得分正常的人具有广泛的认知表现。
Mov Disord. 2014 Sep;29(10):1258-64. doi: 10.1002/mds.25924. Epub 2014 Jul 29.
5
Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?早期帕金森病的生活质量与轻度认知障碍:亚型有影响吗?
J Parkinsons Dis. 2014;4(3):331-6. doi: 10.3233/JPD-140390.
6
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study.描述帕金森病发病患者轻度认知障碍的特征:ICICLE-PD 研究。
Neurology. 2014 Jan 28;82(4):308-16. doi: 10.1212/WNL.0000000000000066. Epub 2013 Dec 20.
7
Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database.痴呆和轻度认知障碍的临床病因诊断稳定性:来自多中心纵向数据库的结果。
Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):750-8. doi: 10.1177/1533317513504611.
8
Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.认知障碍前期恢复正常的患者向痴呆进展的风险更高。
Neurology. 2014 Jan 28;82(4):317-25. doi: 10.1212/WNL.0000000000000055. Epub 2013 Dec 18.
9
Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.使用帕金森病轻度认知障碍运动障碍学会工作组标准定义认知障碍的最佳截断分数。
Mov Disord. 2013 Dec;28(14):1972-9. doi: 10.1002/mds.25655. Epub 2013 Oct 9.
10
Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.早期帕金森病患者轻度认知障碍的预后:挪威 ParkWest 研究。
JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.